Press "Enter" to skip to content

New patent for Coeptis drug CONSENSI

1
Copyright © DrugPatentWatch. Originally published at New patent for Coeptis drug CONSENSI

Annual Drug Patent Expirations for CONSENSI
Annual Drug Patent Expirations for CONSENSI

Consensi is a drug marketed by Coeptis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has nine patent family members in seven countries.

The generic ingredient in CONSENSI is amlodipine besylate; celecoxib. One supplier is listed for this compound. Additional details are available on the amlodipine besylate; celecoxib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Coeptis drug CONSENSI
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!